Thrombolysis may be beneficial later and in older patients suffering an acute stroke

About 1.44 to 1.64 million cases of new stroke occur each year in India, with stroke sufferers losing over 6 million disability-adjusted life years (DALYs) annually due to death and disability, according to data from the World Health Organization (WHO).

Thrombolysis with recombinant tissue plasminogen activator (rt-PA) is used to treat many patients with acute ischemic stroke, but typically not those aged over 80 years or reporting for care more than 3 hours after symptom onset; mainly because these populations were never studied in clinical trials. Now, a new trial published online and ahead-of-print in The Lancet provides data supporting rt-TPA use in a wider range of patients up to 6 hours after stroke onset.

The IST-3 researchers conducted an international, randomized, open-label controlled trial in...

Log in or register for free to continue reading
Register Now For Free Already Registered? Log In
This entry was posted in Geriatrics, Neurology, Neurology Featured 2, Non-Communicable Disease, Pharmacology, Primary Care and tagged , , , , , , , , , . Volume: .

Post a Comment

You must be logged in to post a comment.